Functional cross talk between the Fanconi anemia and ATRX/DAXX histone chaperone pathways promotes replication fork recovery
Open Access
- 8 May 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 29 (7) , 1083-1095
Abstract
Fanconi anemia (FA) is a chromosome instability syndrome characterized by increased cancer predisposition. Specifically, the FA pathway functions to protect genome stability during DNA replication. The central FA pathway protein, FANCD2, locates to stalled replication forks and recruits homologous recombination (HR) factors such as CtBP interacting protein (CtIP) to promote replication fork restart while suppressing new origin firing. Here, we identify alpha-thalassemia retardation syndrome X-linked (ATRX) as a novel physical and functional interaction partner of FANCD2. ATRX is a chromatin remodeler that forms a complex with Death domain-associated protein 6 (DAXX) to deposit the histone variant H3.3 into specific genomic regions. Intriguingly, ATRX was recently implicated in replication fork recovery; however, the underlying mechanism(s) remained incompletely understood. Our findings demonstrate that ATRX forms a constitutive protein complex with FANCD2 and protects FANCD2 from proteasomal degradation. ATRX and FANCD2 localize to stalled replication forks where they cooperate to recruit CtIP and promote MRE11 exonuclease-dependent fork restart while suppressing the firing of new replication origins. Remarkably, replication restart requires the concerted histone H3 chaperone activities of ATRX/DAXX and FANCD2, demonstrating that coordinated histone H3 variant deposition is a crucial event during the reinitiation of replicative DNA synthesis. Lastly, ATRX also cooperates with FANCD2 to promote the HR-dependent repair of directly induced DNA double-stranded breaks. We propose that ATRX is a novel functional partner of FANCD2 to promote histone deposition-dependent HR mechanisms in S-phase.Keywords
Funding Information
- American Cancer Society (RSG-13-039-01-DMC)
- National Institutes of Health (CA194871, GM088351, CA112775)
- National Cancer Institute (CA190492)
- National Institutes of General Medical Sciences (GM 074917)
- Korean Institute for Basic Science (IBS-R022-A1)
This publication has 61 references indexed in Scilit:
- FANCD2 regulates BLM complex functions independently of FANCI to promote replication fork recoveryNucleic Acids Research, 2013
- Double-Strand Break Repair-Independent Role for BRCA2 in Blocking Stalled Replication Fork Degradation by MRE11Cell, 2011
- Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeresProceedings of the National Academy of Sciences, 2010
- Metnase promotes restart and repair of stalled and collapsed replication forksNucleic Acids Research, 2010
- Distinct Factors Control Histone Variant H3.3 Localization at Specific Genomic RegionsCell, 2010
- PARP is activated at stalled forks to mediate Mre11‐dependent replication restart and recombinationThe EMBO Journal, 2009
- MRE11–RAD50–NBS1 is a critical regulator of FANCD2 stability and function during DNA double‐strand break repairThe EMBO Journal, 2009
- The FANC pathway and BLM collaborate during mitosis to prevent micro-nucleation and chromosome abnormalitiesNature Cell Biology, 2009
- Identification of the FANCI Protein, a Monoubiquitinated FANCD2 Paralog Required for DNA RepairCell, 2007
- A novel ubiquitin ligase is deficient in Fanconi anemiaNature Genetics, 2003